BALLIET JENNIFER 4
4 · NEOGENOMICS INC · Filed Mar 3, 2020
Insider Transaction Report
Form 4
BALLIET JENNIFER
Vice President of HR
Transactions
- Tax Payment
Common Stock
2020-03-01−212→ 22,650 total - Award
Common Stock
2020-03-02+2,330→ 24,980 total - Award
Common Stock
2020-03-02$28.33/sh+15,006$425,120→ 15,006 totalExercise: $28.33From: 2021-03-02Exp: 2027-03-02→ Common Stock (15,006 underlying)
Holdings
- 20,000
Stock Option (Right to Buy)
Exercise: $7.52From: 2018-04-28Exp: 2022-04-28→ Common Stock (20,000 underlying) - 17,496
Stock Option (Right to Buy)
Exercise: $19.60From: 2020-03-01Exp: 2024-03-01→ Common Stock (17,496 underlying) - 48,334
Stock Option (Right to Buy)
Exercise: $8.03From: 2019-02-26Exp: 2023-02-26→ Common Stock (48,334 underlying)
Footnotes (5)
- [F1]Shares withheld by NeoGenomics Inc. to satisfy the tax obligations in connection with the March 1, 2020 vesting of restricted stock.
- [F2]On April 28, 2017, Ms. Balliet was granted 60,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F3]On February 26, 2018, Ms. Balliet was granted 72,500 stock options. These options vest ratably over the first three anniversary dates of the grant date.
- [F4]On March 1, 2019, Ms. Balliet was granted 17,496 stock options. These options vest ratably over the first four anniversary dates of the grant date.
- [F5]On March 2, 2020, Ms. Balliet was granted 15,006 stock options. These options vest ratably over the first four anniversary dates of the grant date.